920023-47-8 Usage
Derivative of indole-3-carboxylic acid
1H-Indole-3-carboxylic acid, 6-chloro-2-methylis derived from the core structure of indole-3-carboxylic acid, which is a naturally occurring compound found in various plants and animals.
Chlorine and methyl group substitution
The compound has a chlorine atom attached to the carbon atom at the 6th position and a methyl group attached to the carbon atom at the 2nd position. This substitution modifies the properties and reactivity of the parent indole-3-carboxylic acid.
Potential anti-inflammatory properties
1H-Indole-3-carboxylic acid, 6-chloro-2-methylhas been studied for its potential to reduce inflammation, which could be useful in the development of anti-inflammatory drugs.
Potential antitumor properties
The compound has also been researched for its possible ability to inhibit tumor growth, making it a candidate for the development of antitumor medications.
Use as an intermediate in synthesis
1H-Indole-3-carboxylic acid, 6-chloro-2-methylis used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals, making it a valuable compound in the production of these products.
Value in scientific research and development
The unique chemical structure and properties of 1H-Indole-3-carboxylic acid, 6-chloro-2-methylmake it an important compound for research and development in medicinal chemistry, pharmaceuticals, and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 920023-47-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,0,0,2 and 3 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 920023-47:
(8*9)+(7*2)+(6*0)+(5*0)+(4*2)+(3*3)+(2*4)+(1*7)=118
118 % 10 = 8
So 920023-47-8 is a valid CAS Registry Number.
920023-47-8Relevant articles and documents
INDOL-3-YL-CARBONYL-SPIRO-PIPERIDINE DERIVATIVES AS V1A RECEPTOR ANTAGONISTS
-
Page/Page column 113, (2008/06/13)
The invention relates to indol-3-yl-carbonyl-spiro-piperidine derivatives which act as V1a receptor antagonists and which are represented by Formula I: wherein the spiro-piperidine head group A and the residues R1, R2 and R3 are as defined herein. The invention further relates to pharmaceutical compositions containing such compounds, methods for preparing the compounds and pharmaceutical compositions, and their use in the treatment of dysmenorrhea, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder, anxious and depressive disorders.
Indol-3-y-carbonyl-piperidin and piperazin-derivatives
-
Page/Page column 22, (2010/11/25)
The present invention relates to indol-3-yl-carbonyl-piperidin and piperazin derivatives which act as V1a receptor antagonists and which are represented by Formula I: wherein the residues R1 to R3 are as defined herein. The invention
